 Connection
Jennifer Janusz to Neurofibromatosis 1
This is a "connection" page, showing publications Jennifer Janusz has written about Neurofibromatosis 1.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.202 |
|
|
|
-
Janusz JA, Klein-Tasman BP, Payne JM, Wolters PL, Thompson HL, Martin S, de Blank P, Ullrich N, Del Castillo A, Hussey M, Hardy KK, Haebich K, Rosser T, Toledo-Tamula MA, Walsh KS. Recommendations for Social Skills End Points for Clinical Trials in Neurofibromatosis Type 1. Neurology. 2021 08 17; 97(7 Suppl 1):S73-S80.
Score: 0.750
-
Klein-Tasman BP, Lee K, Thompson HL, Janusz J, Payne JM, Pardej S, de Blank P, Kennedy T, Janke KM, Castillo AD, Walsh KS. Recommendations for Measurement of Attention Outcomes in Preschoolers With Neurofibromatosis. Neurology. 2021 08 17; 97(7 Suppl 1):S81-S90.
Score: 0.187
-
Walsh KS, Janusz J, Wolters PL, Martin S, Klein-Tasman BP, Toledo-Tamula MA, Thompson HL, Payne JM, Hardy KK, de Blank P, Semerjian C, Gray LS, Solomon SE, Ullrich N. Neurocognitive outcomes in neurofibromatosis clinical trials: Recommendations for the domain of attention. Neurology. 2016 Aug 16; 87(7 Suppl 1):S21-30.
Score: 0.134
-
Walsh KS, Janusz J, Wolters PL, Moll HA, van der Vaart T, Rietman AB. Behavioral and cognitive outcomes for clinical trials in children with neurofibromatosis type 1. Neurology. 2016 05 10; 86(19):1849-50.
Score: 0.131
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|